Navigation Links
AACR, Komen for the Cure honor researcher with lecture on science of cancer health disparities
Date:10/26/2012

SAN DIEGO The American Association for Cancer Research is pleased to announce that Claudia R. Baquet, M.D., M.P.H., will present the third annual AACR Distinguished Lecture on The Science of Cancer Health Disparities, funded by Susan G. Komen for the Cure.

Baquet will deliver her lecture, "Advancing the Science of Cancer Health Disparities: The Case for Public Trust, Bioethics, Research Literacy and Biospecimen Science," on Saturday, Oct. 27 during the opening plenary session of the Fifth AACR Conference on The Science of Cancer Health Disparities, in San Diego, Calif., which begins at 6:30 p.m. PT.

Members of the media who cannot attend the conference in person can listen to Baquet's lecture, along with the keynote address given by Howard Koh, M.D., M.P.H., assistant secretary for health at the U.S. Department of Health and Human Services, using the following information:


U.S./Canada (toll free): 1 (800) 446-2782
International (toll call): 1 (847) 413-3235

Baquet is being honored for her contributions to the science of cancer health disparities, and for laying the foundation for the field of research that is now called "health disparities," dating back to her landmark research at the National Cancer Institute (NCI) and her role on the Secretary's Task Force on Black and Minority Health Chapters on Cancer and Health Services.

"We are pleased to recognize Dr. Baquet with this distinguished lectureship," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "Her outstanding leadership and research efforts in cancer health disparities have elevated the field, leading to policy change at the NCI in how race- and ethnic-specific data are included in cancer statistics. Dr. Baquet is truly an advocate for improved health care, specifically among those in underserved communities."

Founded in 2010, the AACR Distinguished Lecture on the Science of Cancer Health Disparities recognizes an
'/>"/>

Contact: Tara Yates
tara.yates@aacr.org
215-446-7110
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Kroenke honored for outstanding contributions in clinical research training
2. Callahan honored for improving older adults health in their doctors offices
3. Neuropsychologist receives University of Houstons highest faculty honor
4. Amyotrophic Lateral Sclerosis Association honors Dr. Robert Baloh, M.D.
5. US Army internal medicine Masters, Fellows honored by American College of Physicians
6. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
7. Mayo Clinic Alzheimers researcher honored twice in a month
8. Girls response to honor-related violence
9. USHEALTH Advisors L.L.C. Honored as Bronze Stevie® Award Winner in 2012 American Business Awards
10. MCG student receives national medical honor society research fellowship
11. American Chemical Societys highest honor to Peter Stang
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 McGuff Pharmaceuticals, Inc. ... Drug Application (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, ... Squibb’s drug fomerly known as Delalutin™. We are ... the anticipated approval and market introduction dates for McGuff’s ... status of our pending ANDA, to date, McGuff has ...
(Date:6/19/2013)... Calculating insurance rates is a complex process that ... and of course their own company policies. This process ... from company to company, and why by shopping around for ... often save, as car insurance can be a hefty expense ... the top factors that determine their car insurance premiums. ...
(Date:6/19/2013)... June 19, 2013 Sudden cardiac arrest can ... sets in an average of 5 minutes after cardiac arrest, ... 11 minutes. This means that death is highly probable if ... readily available for use. In response to this dire reality, ... to Save Lives Act (H.R. 2308) which would provide support ...
(Date:6/19/2013)... June 19, 2013 Anant Goel, CEO at ... changing rapidly. The first industrial revolution began in Britain in ... industry… when the factory was born. The second industrial revolution ... the moving assembly line and ushered in the age of ... the 21st century. Manufacturing is going digital and this could ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Indosoft ... Center ACD for Asterisk, announced today the ... 5.7. This enhancement offers improved options for extracting, ... dashboards for effective contact center management. , Large ... real-time captured as it happens from the call ...
Breaking Medicine News(10 mins):Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 3Health News:AED.com Supports Automated External Defibrillator (AED) Legislation in Schools in US and UK 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 3Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 4Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2
... 2011) Active children need to be watered with ... than a sports drink or water itself, say researchers ... summer weather, says Brian Timmons, research director of the ... principal investigator of the study. "Children become ...
... care costs arising from pressure ulcers, commonly known as ... in emergency departments, according to new research from the ... are at high risk for pressure ulcers in part ... researchers found that while the average cost of upgrading ...
... 17, 2011) Patients with clinically diagnosed superficial vein thrombosis (SVT), ... that commonly resolves on its own without treatment, are four ... a dangerous, often life-threatening condition, according to study results ... Journal of the American Society of Hematology (ASH). ...
... Reporter , WEDNESDAY, Aug. 17 (HealthDay News) -- Researchers ... useful in identifying women who have a higher risk ... This particular antibody, which was detected in blood, ... called mesothelin. This protein is present in advanced ovarian ...
... The Medical College of Wisconsin investigating latex allergy in ... health strategy to prevent allergic sensitization is by stopping ... studies pointed out this association of latex allergy to ... completely confirm this link in specific workers. Reducing the ...
... treating chronic wounds on patients in the United States. These ... than six million people who have them. The most common ... to venous disease (conditions related to or caused by veins ... but the quality of evidence showing which treatments work better ...
Cached Medicine News:Health News:Better mattresses improve care, cut hospital costs: U of T study 2Health News:Common vein condition increases risk for developing life-threating blood clots 2Health News:Blood Antibody May Signal Start of Ovarian Cancer 2Health News:Blood Antibody May Signal Start of Ovarian Cancer 3Health News:Using powder-free latex gloves reduces latex allergy rate in health care workers 2Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 2Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 3
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- Today leading ... all new data ranking Pharmaceutical web sites for usability, ... Sciences, User Experience Cloud platform, which compares how people ... on the web. The top three performers ... convert people overall. The bottom performers have usability problems, ...
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- In its first ... pharmaceutical company dedicated to advancing development of ... sustained release drug therapies in patient disease ... announced the acquisition of Enzon Pharmaceutical,s PEGylation ... associated product pipeline. Acquisition of this technology ...
(Date:6/19/2013)... 19, 2013  Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... number one overall pharmacy equipment vendor in the ... a leading independent healthcare research firm, compared the ... its annual rankings. Omnicell also received the prestigious ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4
...   Unigene Laboratories, Inc. (OTCBB: UGNE), ... of peptide-based therapeutics, announced that Ashleigh Palmer, President and ... the Biotech Showcase™ 2012 in San Francisco, CA on ... p.m. ET).  Mr. Palmer,s presentation will include an overview of ...
... Md., Jan. 4, 2012 /PRNewswire-iReach/ -- ... pharmaceutical company focused exclusively in the HIV-1 therapeutic ... to provide medicinal chemistry services to support DFH ... maturation inhibitor drugs. Maturation inhibitors are a novel ...
Cached Medicine Technology:Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 3
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: